Open original FDA record ↗Recall record
- FDA identifier
- Z-1326-2019
- Company in FDA record
- PENTAX of America Inc
- FDA record creation date
- May 14, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Incorrect default dose and dose increments may be transmitted to the controller if the catheter RFID tag is not correct or is not being correctly or completely readable by the controller.
Source facts
- Action
- Letters dated 12/3/2018 were issued via USPS mailing on 12/3/2018 explaining the issue and instructing the customer to discontinue use of the device and to ensure all potential users in the customer facility are aware of the recall notification and recommended actions. For questions regarding this action, please contact PENTAX Medical Customer Service. Tel: 650-318-5899 (8:30 AM 5:00 PM, Monday Friday, PST) Fax: 650-318-5899 Email: RMA@C2Therapeutics.com
- Initiated
- 2018-12-03
- Root cause
- Under Investigation by firm
- Terminated
- 2020-08-14
- Distribution
- Distribution was made to CA, DC, FL, LA, MA, MD, MN, NC, NJ, NY, OH, PA, SC, TN, TX, VA, and WA. There was no government/military distribution. Foreign distribution was made to Canada, Germany, and the Netherlands.
- Recall number
- Z-1326-2019
- Recall status
- Terminated
- CDRH record ID
- 171258
- FDA record created
- 2019-05-14
- Recall event number
- 82274